Shares: Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SHIRE Pharmaceuticals, marketing and licensing prescription drugs, lifted the recent gloom over the biotech sector with a 45.5p rise to 409p. Shire cleared a stock overhang by completing a global share offering which included listing on Nasdaq, the US market for hi-tech stocks. Shire offered 21 million shares at 343p, raising pounds 72m. In the past year, the shares have soared by close to 90 per cent.
OVER on AIM, hotel minnow Peel Hotels added 7p to 97.5p. The project, which owns the Bull Hotel in Peterborough, has had a better reception than the last time Robert Peel ventured on to the stock market as chief executive of Thistle Hotels. There he was forced out by institutional shareholders after a disappointing share price performance following flotation. But shares in Peel Hotels have risen by 60 per cent since coming to the market at 60.5p a week ago.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments